EUPAVIDY
DEAD

Serial Number

97860520

Owner

Athira Pharma, Inc.

Attorney

Kevin S. Costanza

Filing Date

Mar 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EUPAVIDY Trademark

Serial Number: 97860520

EUPAVIDY is a trademark filed by Athira Pharma, Inc. on March 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Athira Pharma, Inc. (11 trademarks)

Suite 104
Bothell, WA 98011

Entity Type: 03

Trademark Details

Filing Date

March 28, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceuticals, pharmaceutical preparations and pharmaceutical agents; pharmaceuticals in the nature of small molecule chemical compounds; pharmaceuticals for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical agents for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 1, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 1, 2025 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 4, 2024 GNFN
FINAL REFUSAL E-MAILED
Dec 4, 2024 GNFR
FINAL REFUSAL WRITTEN
Dec 4, 2024 CNFR
ASSIGNED TO EXAMINER
Oct 25, 2024 DOCK
ASSIGNED TO EXAMINER
Jul 16, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 15, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 26, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 26, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 18, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2023 NWOS
NEW APPLICATION ENTERED
Mar 31, 2023 NWAP